Patrick Deas

Double-Blind , Placebo-Controlled Study Behaviors and Clinician-and Informant-Rated ADHD Symptoms in Adults : Data From a Randomized , Treatment With Lisdexamfetamine Dimesylate Improves Self-and Informant-Rated Executive Function

L. Adler, R. Weisler, L. Ginsberg, 2014 .

Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study.

L. Adler, R. Weisler, B. Dirks, 2013, The Journal of clinical psychiatry.

Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study

L. Adler, R. Weisler, K. Saylor, 2013, BMC Psychiatry.

Treatment With Lisdexamfetamine Dimesylate Improves Self- and Informant-Rated Executive Function Behaviors and Clinician- and Informant-Rated ADHD Symptoms in Adults: Data From a Randomized, Double-Blind, Placebo-Controlled Study

L. Adler, R. Weisler, L. Ginsberg, 2017, Journal of attention disorders.